ADAM8 and hepatocellular carcinoma: Overall, these results suggest that SpdCas9-VPR synergistically combined with the MS2-MCP-p65-HSF1 recruiting system, or the SpdCas9-VPR alone are the most effective CRISPRa platforms for the reactivation of several highly silenced TSGs in HCC cells.